Dubai, UAE – In recognition of World Arthritis Day (WAD), the Middle East Arthritis Foundation (MEAF), a non-profit dedicated ...

UCB has received US FDA approval for BIMZELX (bimekizumab-bkzx) to treat adults with three inflammatory conditions.

Arthritis is a broad term that refers to the inflammation of joints resulting in joint pain, swelling, stiffness and limited ...

Consulting with a healthcare provider to tailor a balanced calcium intake plan, integrating both dietary sources and ...

Paediatric rheumatology research is not doing enough to serve patients and paediatric trial designs are unacceptable for children and families. This is the critical view of a UK-based patient and ...

More than 75% of the cohort started a TNF inhibitor during the selected time frame. For the rest, JAK inhibitors were the ...

Turmeric and ginger are used for many possible health benefits. Learn how this combination can be used and what research ...

The DWP has revealed over 461,000 people across Great Britain are claiming Attendance Allowance support for arthritis, making it the most claimed-for health condition by those over the State Pension a ...

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

The US Food and Drug Administration has approved bimekizumab -bkzx (Bimzelx; UCB) for adult patients with active psoriatic ...

Attendance Allowance for arthritis, receiving up to £434, the DWP figures have shown, amid the Cost of Living crisis.